TVARDI THERAPEUTICS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2012 | $-6.0M | $-6.0M | — | $61.0K |
| FY2013 | $2.8M | $2.8M | $5.0K | $123.0K |
| FY2014 | $-17.6M | $-17.7M | $42.0K | $1.4M |
| FY2015 | $-21.5M | $-21.5M | $20.0K | $2.5M |
| FY2016 | $-47.4M | $-48.1M | $717.0K | $2.8M |
| FY2017 | $-54.8M | $-54.9M | $58.0K | $5.8M |
| FY2018 | $-22.3M | $-22.4M | $73.0K | $9.5M |
| FY2019 | $-109.2M | $-109.2M | $18.0K | $12.6M |
| FY2020 | $-5.5M | $-5.8M | $349.0K | $14.8M |
| FY2021 | $-60.1M | $-60.1M | $39.0K | $20.8M |
| FY2022 | $-78.7M | $-78.8M | $43.0K | $17.7M |
| FY2023 | $-92.1M | $-94.5M | $2.4M | $13.7M |
| FY2024 | $-18.3M | $-19.4M | $1.0M | $319.0K |
| FY2025 | $-23.5M | $-23.5M | — | $1.4M |